Scivita Medical nabs $62m and 14 more deal updates from Greater China

Endoscopy products producer Scivita Medical Technology Co., Ltd has raised 400 million yuan ($62 million) in a Series B round of financing from new investors including New York-based Hudson Bay Capital and Chinese investment firm Prime Capital. 

Existing investors – Lilly Asia Ventures (LAV), Hillhouse Capital’s venture unit GL Ventures, Matrix Partners China – re-upped in the round. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter